The inhibitory anti-NBCn1 antibodies can lower tumor growth and—under acidic conditions—cause G2/M-phase cell cycle accumulation and elevated apoptosis in triple-negative breast cancer cells. This evidence concerns the gene SLC4A7 and triple-negative breast carcinoma.